Drug Profile
Research programme: oligonucleotide therapeutics - AdiuTide
Alternative Names: ATP-00001; ATP-00002; ATP-10001Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator AdiuTide Pharmaceuticals
- Class Oligonucleotides
- Mechanism of Action Immunostimulants; Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Cancer; Infections
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for preclinical development in Asthma in Germany
- 28 Feb 2018 No recent reports of development identified for preclinical development in Cancer in Germany
- 28 Feb 2018 No recent reports of development identified for preclinical development in Infections in Germany